Gammagard Kit
Product Images NDC 0944-2658

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Gammagard (NDC 0944-2658). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Gammagard 01)

An instructional illustration showing hands handling a vial adapter, positioned above two labeled bottles, one marked as Concentrate and the other as Diluent, demonstrating preparation steps for GAMMAGARD S/D Immune Globulin Intravenous (Human) Kit.*

FDA Label Image

Figure (Gammagard 02)

An instructional illustration labeled '3a' showing hands preparing a vial labeled 'Diluent.' One hand holds the vial while the other hand attaches or inserts a device into the vial's stopper, demonstrating a step in the preparation process.*

FDA Label Image

Figure (Gammagard 03)

An instructional diagram showing a close-up detail of a component on the top of a container, likely part of the GAMMAGARD S/D immune globulin intravenous kit. The zoomed inset highlights the connection or valve area, illustrating assembly or usage steps for the kit.*

FDA Label Image

Figure (Gammagard 04)

Instructional illustrations showing preparation steps for GAMMAGARD S/D immune globulin intravenous kit. The first image depicts adding diluent to concentrate, while the second image, crossed out, indicates not to pour diluent directly into the concentrate container.*

FDA Label Image

Figure (Gammagard 05)

An instructional illustration showing a step labeled '5a' for mixing GAMMAGARD S/D Immune Globulin Intravenous (Human) kit components. The diagram depicts attaching a diluent bottle above a concentrate vial, with arrows indicating the diluent is to be added to the concentrate by inverting the diluent bottle onto the vial.*

FDA Label Image

Figure (Gammagard 06)

An instructional diagram showing how to press firmly on a connected infusion setup, part of the administration process for GAMMAGARD S/D Immune Globulin Intravenous (Human) kit. It depicts hands holding the infusion container and connector, highlighting the mechanism interaction.*

FDA Label Image

Figure (Gammagard 07)

Illustration showing a hand holding a container, depicting the step of handling or positioning the GAMMAGARD S/D Immune Globulin Intravenous (Human) kit component. The image includes an arrow indicating a motion or rotation of the container.*

FDA Label Image

Principal Display Panel (5 g/96 mL Bottle Label)

Label for GAMMAGARD S/D Immune Globulin Intravenous (Human) 5g/96mL kit, a plasma derivative by Takeda Pharmaceuticals America, Inc. The label includes storage instructions, a barcode, and two identical sections noting IgA less than 1 µg/mL in a 5% solution with spaces for lot number, expiration date, and date.*

FDA Label Image

Principal Display Panel (96 mL Bottle Label)

Label of sterile water for injection, USP, 96 mL single-dose container by Baxter Healthcare Corporation. The label indicates it is for reconstitution of accompanying product, not to be used unless clear and isotonic. Manufactured by Baxter Healthcare Corporation, Deerfield, IL, and imported by Baxter Corporation, Mississauga, ON. Includes lot and expiration date fields.*

FDA Label Image

Principal Display Panel (Kit Carton)

Packaging label for GAMMAGARD S/D Immune Globulin Intravenous (Human) Kit by Takeda Pharmaceuticals America, Inc. The label highlights a 5 gram dosage in a 96 mL volume, with IgA less than 1 µg/mL in a 5% solution. It includes usage instructions, storage information, and manufacturer details, featuring the Shire logo prominently.*

FDA Label Image

Principal Display Panel (10 g/192 mL Bottle Label)

Label for GAMMAGARD S/D Immune Globulin Intravenous (Human) kit by Takeda Pharmaceuticals America, Inc. It shows a 10g dosage strength in a 5% solution with IgA less than 1 µg/mL. The label includes storage instructions to not exceed 25°C (77°F) and not to freeze. Manufacturer is listed as Baxalta US Inc., Lexington, MA.*

FDA Label Image

Principal Display Panel (192 mL Bottle Label)

Sterile Water for Injection, USP label from Baxter Healthcare Corporation. The label states it is a nonpyrogenic, single-dose container of 192 mL. It includes instructions that the water is for reconstitution of the accompanying product and warnings about its use. The label also provides manufacturing and import information, along with Rx only status and trademark notices.*

FDA Label Image

Principal Display Panel (Kit Carton)

Packaging label for GAMMAGARD S/D Immune Globulin Intravenous (Human) kit by Takeda Pharmaceuticals America, Inc. The label states 10g in 192mL with IgA less than 1 µg/mL in a 5% solution. It includes storage instructions and identifying barcodes, with the Shire logo displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.